GAMMA Investing LLC raised its stake in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 38.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 2,858 shares of the company’s stock after purchasing an additional 789 shares during the period. GAMMA Investing LLC’s holdings in Henry Schein were worth $198,000 as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of the stock. Cromwell Holdings LLC lifted its position in shares of Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after buying an additional 170 shares during the last quarter. Versant Capital Management Inc lifted its holdings in Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after acquiring an additional 335 shares during the last quarter. Farther Finance Advisors LLC grew its holdings in shares of Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after purchasing an additional 346 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its position in shares of Henry Schein by 282.1% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock worth $109,000 after purchasing an additional 1,100 shares during the period. Finally, Wilmington Savings Fund Society FSB bought a new stake in shares of Henry Schein in the 3rd quarter worth approximately $109,000. Institutional investors and hedge funds own 96.62% of the company’s stock.
Wall Street Analyst Weigh In
A number of brokerages recently commented on HSIC. Barrington Research restated an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a research note on Wednesday, November 6th. Evercore ISI upped their price target on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and lifted their price objective for the company from $69.00 to $84.00 in a research report on Monday. Mizuho assumed coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price for the company. Finally, StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Seven investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $79.40.
Henry Schein Stock Down 0.9 %
HSIC opened at $71.06 on Thursday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The company has a market capitalization of $8.86 billion, a PE ratio of 29.24, a P/E/G ratio of 2.30 and a beta of 0.89. The stock’s fifty day moving average is $72.13 and its 200-day moving average is $70.37. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.63.
Henry Schein (NASDAQ:HSIC – Get Free Report) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.17 by $0.05. The firm had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue for the quarter was up .4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.32 earnings per share. On average, equities analysts predict that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.
Insider Buying and Selling
In related news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.14% of the stock is currently owned by insiders.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Articles
- Five stocks we like better than Henry Schein
- What Are Dividend Contenders? Investing in Dividend Contenders
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Short Selling: How to Short a Stock
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Canada Bond Market Holiday: How to Invest and Trade
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.